Visalytics
Visalytics
approved EB-2 (NIW)

Equity Research Associate

Cell Biology · China · 2023-09-20

Processing Time
89 days
Decision Date
2023-09-20
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in signal transduction and programmed cell death (apoptosis) to identify molecular mechanisms of disease progression. Her work focuses on regulating cholesterol uptake, cellular stress responses, and cancer therapy targets to innovate treatments in oncology and cardiovascular health.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research in apoptosis and signal transduction has significant implications for cancer therapy and cardiovascular health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, and 425 citations demonstrate her capability to lead research in cell biology.

3 Waiver Benefit to the U.S. Met

The petitioner's unique expertise and the global relevance of her work make it beneficial for the U.S. to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in biological sciences and a record of 8 peer-reviewed journal articles with 425 citations. Her authority in the field was evidenced by 10 verified peer reviews, editorial board membership, and support from four expert recommendation letters. The case satisfied all three Dhanasar prongs by demonstrating the global scientific value of her research across 40 academic institutions.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Reference Letters Dependent
Judging Experience
Original Contributions

Similar Cases

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
New Jersey 6 days 2024-10-10
The petitioner proposes to develop advanced statistical models using real-world evidence and omics data to identify novel biomarkers for diseases. This work aims to facilitate the development of precision drug therapies and enhance the understanding of cancer, metabolic disorders, and cardiovascular diseases.
View Case

Research Fellow

Biotechnology · China

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2025-02-18
The petitioner proposes to utilize single-cell multi-omic analysis and high-throughput microscopy to identify molecular and systems-level processes driving carcinogenesis and immune responses. This work aims to uncover mechanisms governing cellular decision-making to enable more precise and effective cancer treatments.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Texas 106 days 2022-05-04
The petitioner proposes to continue her research in disease genetics and cellular therapeutics, specifically investigating stem cell-based cancer therapeutics and developing functional biomarkers for cancer treatment. Her work focuses on determining the mechanisms underpinning the development of cancer and neurodegenerative diseases to reduce their global impact.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-09-20.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 89 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist